ClinicalTrials.gg
Sign In

Intracranial Hypertension clinical trials

The registry lists 165 studies for Intracranial Hypertension across more than 10 countries. 36 are recruiting or about to start. 90 of them are mainly about Intracranial Hypertension (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Pseudotumor Cerebri too: 209 studies, 53 open.

Get an email when these change. Save the Intracranial Hypertension studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
73
Status unknown
31
Recruiting
23
Not yet recruiting
13
Terminated
11
Withdrawn
8

Phase

Phase 2
7
Phase 3
6
Phase 4
4
Phase 1
2
Early Phase 1
1

Where

United States
29
Turkey
26
France
16
United Kingdom
9
Egypt
8
China
8

Who runs them

HeadSense Medical (5) · Assiut University (4) · Duke University (3) · Capital Medical University (3) · Rigshospitalet, Denmark (3) · University Hospital, Montpellier (3) · Konya City Hospital (2) · University Hospital, Grenoble (2)

What is being tested here

Drugs under test in Intracranial Hypertension studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mannitol125
Sodium Lactate134
Bupivacaine001
Azd-4017001
Acetazolamide001
FS 069001
Ketamine001
Propofol001
Cisatracurium001
Dexmedetomidine001

Coming up

0phase 3 studies under way
13studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 23 Intracranial Hypertension studies recruiting now, 11 (48%) set no upper age limit and 5 (22%) stop at 75 or younger. 3 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (22%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
103 (13%)3 (13%)
1822 (96%)22 (96%)
3021 (91%)21 (91%)
4021 (91%)21 (91%)
5021 (91%)21 (91%)
6521 (91%)21 (91%)
7519 (83%)19 (83%)
8513 (57%)13 (57%)

Across all 165 studies, recruiting or not: 35% stop at 75 or younger and 24% at 65; 21% take children; 4% are for women only and 2% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Intracranial Hypertension studies take

Of 44 observational studies under Intracranial Hypertension, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo6–39 · 38 studies—15 mo6–39 · 37 studies
Observational31 mo11–62 · 44 studies—31 mo11–62 · 42 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 165. Browse all 165 → or search them.